Abstract
Background Epilepsy is one of the most prevalent neurological disorders, affecting 50 million individuals worldwide. The aetiology of epilepsy is known to have genetic contributions, yet headline results obtained from genome-wide association studies (GWAS) of epilepsy have not always been consistent. We undertook a systematic review of all the findings from this work in order to identify risk variants for epilepsy.
Methods This systematic review was conducted in accordance with the updated PRISMA protocol. EbscoHost, PubMed, Scopus, Web of Science and Primo were searched between the years 2010 – 2024. The quality of each of the studies was evaluated using the Q-Genie tool.
Results 11 studies were included for full extraction, analysis, and quality assessment. Across the identified studies, 79 SNPs, located in 64 genes, were significantly associated with epilepsy at the genome-wide level. The majority of the variants were intronic and intergenic, with the well documented SCN1A the most widely reported gene involved across studies. Two SNPs, rs2292096 and rs149212747, linked respectively to focal epilepsy (FE) and status epilepticus, were exclusively identified in individuals of Asian ancestry, alongside an Asian-exclusive synonymous variant (rs3782886) in BRAP and a missense variant (rs671) in ALDH2.
Conclusions Genes which encode for ion and transport channels, transcription factors, ubiquitin ligase and transporter proteins were identified as potentially involved in the aetiology of epilepsy disorders. The review identified one missense and one synonymous variant which deserve further exploration. Future research should also include populations of more diverse ancestries as this may reveal unique and important epilepsy-associated genes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work reported herein was made possible through funding by the South African Medical Research Council through its Division of Research Capacity Development under the SAMRC Internship Scholarship Programme. The content hereof is the sole responsibility of the authors and does not necessarily represent the official views of the SAMRC.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study made use of publicly available and published data and only. No identifiable, personal or individual level data was used.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
This review was updated in February 2024
Data Availability
As no primary data collection was conducted for this review, all data used in this study are publicly available and can be accessed by referring to the original sources cited in the reference list. For any additional inquiries or requests related to the data used in this systematic review, please feel free to contact the corresponding author of the publication.
